Resmed (RMD) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $242.23, +2.95% vs the prior close of $235.29.
- Volume 1.09M shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
RMD rises 2.9% to $242.23, a 6-month high, 7 up days in a row. Closed at $242.23, +2.95% vs the prior close of $235.29. Day range $237.90–$242.63, opened at $238.16.
RMD daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — RMD rises 2.9% to $242.23, a 6-month high, 7 up days in a row
- Closed at $242.23, +2.95% vs the prior close of $235.29. Day range $237.90–$242.63, opened at $238.16.
- Volume was 1.09M shares, 0.8x its 50-day average of 1.32M.
- Price is +6.9% vs its 50-day average ($226.66) and +7.6% vs its 200-day average ($225.05).
- 52-week range $180.27–$277.67; today's close sits at 64% of that range, 12.8% below the 52-week high.
- That makes 7 straight gains.
Oct 14, 2026 — RMD ends flat (+0.1%) to $235.29, a 1-month high, 6 up days in a row
- Closed at $235.29, +0.11% vs the prior close of $235.04. Day range $232.76–$237.06, opened at $235.58.
- Volume was 1.02M shares, 0.8x its 50-day average of 1.33M.
- Price is +4.0% vs its 50-day average ($226.30) and +4.5% vs its 200-day average ($225.06).
- 52-week range $180.27–$277.67; today's close sits at 56% of that range, 15.3% below the 52-week high.
- That makes 6 straight gains.
Oct 13, 2026 — RMD ends flat (+0.2%) to $235.04, a 1-month high, 5 up days in a row
- Closed at $235.04, +0.19% vs the prior close of $234.60. Day range $233.15–$236.86, opened at $236.59.
- Volume was 891.20K shares, 0.7x its 50-day average of 1.35M.
- Price is +4.0% vs its 50-day average ($226.06) and +4.4% vs its 200-day average ($225.10).
- 52-week range $180.27–$277.67; today's close sits at 56% of that range, 15.4% below the 52-week high.
- That makes 5 straight gains.
Oct 12, 2026 — RMD rises 2.0% to $234.60, a 1-month high, 4 up days in a row
- Closed at $234.60, +1.98% vs the prior close of $230.05. Day range $230.08–$235.98, opened at $231.74.
- Volume was 1.05M shares, 0.8x its 50-day average of 1.35M.
- Price is +4.0% vs its 50-day average ($225.66) and +4.2% vs its 200-day average ($225.15).
- 52-week range $180.27–$277.85; today's close sits at 56% of that range, 15.6% below the 52-week high.
- That makes 4 straight gains.
Oct 9, 2026 — RMD rises 1.5% to $230.05, a 1-month high, 3 up days in a row
- Closed at $230.05, +1.46% vs the prior close of $226.73. Day range $226.42–$231.36, opened at $226.54.
- Volume was 1.00M shares, 0.7x its 50-day average of 1.35M.
- Price is +2.2% vs its 50-day average ($225.19) and +2.2% vs its 200-day average ($225.20).
- 52-week range $180.27–$284.05; today's close sits at 48% of that range, 19.0% below the 52-week high.
- That makes 3 straight gains.
Oct 8, 2026 — RMD rises 0.3% to $226.73
- Closed at $226.73, +0.33% vs the prior close of $225.98. Day range $223.04–$226.88, opened at $225.79.
- Volume was 651.10K shares, 0.5x its 50-day average of 1.36M — lighter than usual.
- Price is +0.9% vs its 50-day average ($224.76) and +0.6% vs its 200-day average ($225.28).
- 52-week range $180.27–$284.87; today's close sits at 44% of that range, 20.4% below the 52-week high.
Oct 7, 2026 — RMD rises 2.4% to $225.98
- Closed at $225.98, +2.40% vs the prior close of $220.69. Day range $221.83–$228.75, opened at $222.27.
- Volume was 1.13M shares, 0.8x its 50-day average of 1.36M.
- Price is +0.7% vs its 50-day average ($224.51) and +0.3% vs its 200-day average ($225.37).
- 52-week range $180.27–$284.87; today's close sits at 44% of that range, 20.7% below the 52-week high.
Oct 6, 2026 — RMD dips 1.0% to $220.69
- Closed at $220.69, -0.97% vs the prior close of $222.86. Day range $219.96–$225.23, opened at $223.90.
- Volume was 972.60K shares, 0.7x its 50-day average of 1.37M.
- Price is -1.6% vs its 50-day average ($224.17) and -2.1% vs its 200-day average ($225.46).
- 52-week range $180.27–$284.87; today's close sits at 39% of that range, 22.5% below the 52-week high.
Oct 5, 2026 — RMD rises 1.8% to $222.86
- Closed at $222.86, +1.81% vs the prior close of $218.89. Day range $218.44–$223.72, opened at $218.44.
- Volume was 976.50K shares, 0.7x its 50-day average of 1.37M.
- Price is -0.4% vs its 50-day average ($223.82) and -1.2% vs its 200-day average ($225.58).
- 52-week range $180.27–$284.87; today's close sits at 41% of that range, 21.8% below the 52-week high.
Oct 2, 2026 — RMD dips 1.0% to $218.89
- Closed at $218.89, -1.02% vs the prior close of $221.15. Day range $218.03–$223.73, opened at $221.66.
- Volume was 898.90K shares, 0.7x its 50-day average of 1.37M.
- Price is -2.0% vs its 50-day average ($223.26) and -3.0% vs its 200-day average ($225.71).
- 52-week range $180.27–$284.87; today's close sits at 37% of that range, 23.2% below the 52-week high.
RMD latest news & SEC filings
Every SEC filing by or about RMD in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 8, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Farrell Michael J. converted options/RSUs into 4,991 shares at $146.34 (≈$730.38K) on Oct 7, 2026; now holds 484,794
- Farrell Michael J. sold 4,991 shares at $226.33 (≈$1.13M) on Oct 7, 2026; now holds 479,803
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 7, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Oct 1, 2026 · ARS — Annual report to shareholders
Annual report to shareholders
Oct 1, 2026 · DEFA14A — Additional proxy materials
Additional proxy materials
Oct 1, 2026 · DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Oct 1, 2026 · 4/A — Amended insider trade report (Form 4/A)
Amended insider trade report (Form 4/A)
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 1, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Leong Justin received an award of 6,461 shares on Aug 14, 2026; now holds 35,489
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 1, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Rider Michael J received an award of 3,230 shares on Aug 14, 2026; now holds 12,718
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 1, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Farrell Michael J. received an award of 13,547 shares on Aug 14, 2026; now holds 479,803
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 1, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 17, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 4.01 — Changed its outside auditor.
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 13, 2026 · 10-K — Annual report (audited full-year financial statements and business review)
Annual report (audited full-year financial statements and business review)
Fiscal year ended Jun 30, 2026:
- Revenue: $5.65B (prior year $5.15B) (+9.9% vs Jun 30, 2025)
- Net income: $1.52B (prior year $1.40B) (+8.8% vs Jun 30, 2025)
- Diluted EPS: $10.43 (prior year $9.51) (+9.7% vs Jun 30, 2025)
Aug 7, 2026 · SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 8.01 — Reported other events the company considers important.
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 7, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade RMD
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: Jul 7, 2026, Apr 30, 2026, Jan 29, 2026. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 0.88% (largest 2.9%). That is a relatively calm stock.
- Liquidity: about 1.13M shares (≈$274.92M) trade per day on average.
- 52-week position: $242.23 vs a range of $180.27–$277.67 (64% of the range).
- Dividends: last ex-dividend date Aug 20, 2026 ($0.66/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Michael J. Farrell sold 4,991 shares on Sep 8, 2026.
- Latest filings: 8-K Sep 1, 2026; 8-K Aug 17, 2026; 10-K Aug 13, 2026.
- Share count: 144.25M shares outstanding (Aug 10, 2026), -1.5% vs a year earlier.
- Listing: NYSE · industry: Surgical & Medical Instruments & Apparatus.
RMD market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 238.16 | 242.63 | 237.90 | 242.23 | 1.09M |
| Oct 14, 2026 | 235.58 | 237.06 | 232.76 | 235.29 | 1.02M |
| Oct 13, 2026 | 236.59 | 236.86 | 233.15 | 235.04 | 891.20K |
| Oct 12, 2026 | 231.74 | 235.98 | 230.08 | 234.60 | 1.05M |
| Oct 9, 2026 | 226.54 | 231.36 | 226.42 | 230.05 | 1.00M |
| Oct 8, 2026 | 225.79 | 226.88 | 223.04 | 226.73 | 651.10K |
| Oct 7, 2026 | 222.27 | 228.75 | 221.83 | 225.98 | 1.13M |
| Oct 6, 2026 | 223.90 | 225.23 | 219.96 | 220.69 | 972.60K |
| Oct 5, 2026 | 218.44 | 223.72 | 218.44 | 222.86 | 976.50K |
| Oct 2, 2026 | 221.66 | 223.73 | 218.03 | 218.89 | 898.90K |
| Oct 1, 2026 | 220.75 | 224.14 | 219.00 | 221.15 | 930.40K |
| Sep 30, 2026 | 222.63 | 224.04 | 220.00 | 221.10 | 1.31M |
| Sep 29, 2026 | 221.96 | 224.22 | 220.32 | 222.83 | 949.40K |
| Sep 28, 2026 | 221.52 | 223.00 | 218.26 | 222.10 | 862.80K |
| Sep 25, 2026 | 221.08 | 223.22 | 220.13 | 222.00 | 760.80K |
| Sep 24, 2026 | 223.08 | 224.50 | 220.39 | 221.89 | 798.80K |
| Sep 23, 2026 | 222.78 | 225.10 | 220.00 | 222.30 | 1.44M |
| Sep 22, 2026 | 226.22 | 227.90 | 221.82 | 221.97 | 1.03M |
| Sep 21, 2026 | 225.16 | 226.52 | 223.34 | 223.61 | 1.07M |
| Sep 18, 2026 | 228.21 | 228.39 | 224.56 | 224.99 | 3.86M |
About Resmed
Resmed (RMD) is listed on the NYSE and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in SAN DIEGO, CA. State of incorporation: DE. Fiscal year ends June 30. SEC CIK 943819.
RMD board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Carol Burt | Director | Nov 24, 2025 |
| Witte Jan De | Director | Nov 26, 2025 |
| Christopher Delorefice | Director | Nov 24, 2025 |
| Karen Drexler | Director | Nov 24, 2025 |
| Peter C Farrell | Director | Sep 4, 2026 |
| Michael J. Farrell | Chairman and CEO | Sep 10, 2026 |
| Harjit Gill | Director | Nov 24, 2025 |
| John Hernandez | Director | Nov 24, 2025 |
| Nicole Mowad-Nassar | Director | Nov 26, 2025 |
| Richard Sulpizio | Director | Nov 21, 2025 |
| Ronald R Taylor | Director | Nov 24, 2025 |
| Desney Tan | Director | Nov 24, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Aaron Bloomer | Chief Financial Officer | May 4, 2026 |
| Michael J. Farrell | Chairman and CEO | Sep 10, 2026 |
| Justin Leong | Chief Product Officer | Nov 24, 2025 |
| Michael J Rider | Global General Counsel | Jun 3, 2026 |
| Brett Sandercock | Chief Financial Officer | May 4, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 8, 2026 | Michael J. Farrell | Sale | 4,991 | $222.44 |
| Sep 2, 2026 | Peter C Farrell | Sale | 970 | $234.73 |
| Aug 7, 2026 | Michael J. Farrell | Sale | 4,991 | $205.69 |
| Aug 5, 2026 | Peter C Farrell | Sale | 8,000 | $225.00 |
| Jul 7, 2026 | Michael J. Farrell | Sale | 4,991 | $218.55 |
| Jun 8, 2026 | Michael J. Farrell | Sale | 4,991 | $193.96 |
| May 7, 2026 | Michael J. Farrell | Sale | 4,991 | $207.82 |
| Apr 7, 2026 | Michael J. Farrell | Sale | 4,991 | $225.50 |
| Apr 1, 2026 | Brett Sandercock | Sale | 1,000 | $224.31 |
| Apr 1, 2026 | Peter C Farrell | Sale | 2,000 | $225.00 |
| Mar 9, 2026 | Michael J. Farrell | Sale | 4,991 | $251.03 |
| Mar 4, 2026 | Peter C Farrell | Sale | 2,000 | $260.22 |
| Mar 2, 2026 | Brett Sandercock | Sale | 1,000 | $254.30 |
| Feb 9, 2026 | Michael J. Farrell | Sale | 4,991 | $273.78 |
| Feb 4, 2026 | Peter C Farrell | Sale | 2,000 | $251.31 |
RMD financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Jun 30, 2026 | $5.65B | $1.52B | 10.43 | $1.81B |
| Jun 30, 2025 | $5.15B | $1.40B | 9.51 | $1.75B |
| Jun 30, 2024 | $4.69B | $1.02B | 6.92 | $1.40B |
| Jun 30, 2023 | $4.22B | $897.56M | 6.09 | $693.30M |
| Jun 30, 2022 | $3.58B | $779.44M | 5.30 | $351.15M |
Latest balance sheet: total assets $8.97B, total liabilities $2.38B, cash $1.47B (as of Jun 30, 2026).
RMD earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $223.24 |
| Jul 7, 2026 | 8-K Item 2.02 (results) | $219.75 |
| Apr 30, 2026 | 8-K Item 2.02 (results) | $213.81 |
| Jan 29, 2026 | 8-K Item 2.02 (results) | $257.61 |
| Oct 30, 2025 | 8-K Item 2.02 (results) | $252.26 |
| Jul 31, 2025 | 8-K Item 2.02 (results) | $271.94 |
| Apr 23, 2025 | 8-K Item 2.02 (results) | $214.44 |
| Jan 30, 2025 | 8-K Item 2.02 (results) | $257.65 |
| Oct 24, 2024 | 8-K Item 2.02 (results) | $239.05 |
| Aug 1, 2024 | 8-K Item 2.02 (results) | — |
| Apr 25, 2024 | 8-K Item 2.02 (results) | — |
| Jan 24, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Stryker (SYK)Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Dexcom (DXCM)Becton Dickinson (BDX)Medline (MDLN)Insulet (PODD)West Pharmaceutical Services (WST)Globus Medical (GMED)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on RMD
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.